DOCSLIB.ORG

Prognostic Values of Stabilin-2 in Hepatocellular Carcinoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prognostic Values of Stabilin-2 in Hepatocellular Carcinoma Prognostic Values of Stabilin-2 in Hepatocellular Carcinoma Zhicheng Du Zhengzhou University First Aliated Hospital https://orcid.org/0000-0002-1257-6619 Pengfei Zhu Zhengzhou University First Aliated Hospital Long Yu Zhengzhou University First Aliated Hospital Kunlun Chen Zhengzhou University First Aliated Hospital Janwen Ye Zhengzhou University First Aliated Hospital Wenlong Zhai ( [email protected] ) https://orcid.org/0000-0003-2559-2105 Primary research Keywords: Hepatocellular carcinoma, Stabilin-2, biomarker, prognostic Posted Date: May 11th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-27280/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/20 Abstract Background: Hepatocellular carcinoma (HCC) is the primary malignancy of the liver. However, biomarkers for early HCC diagnosis are not available. Stabilin (STAB) proteins are scavenger receptors involved in apoptosis and clearance of hyaluronic acid .The role of STAB in HCC has not been previously explored; therefore, the aim of this study was to assess whether STAB gene expression can be used as a novel HCC biomarker. Materials and Methods: Data on 370 HCC patients in the Cancer Genome Atlas database and 221 patients in the Gene Expression Comprehensive Database were retrieved and analyzed. Kaplan–Meier analysis and Cox regression model were used to calculate median survival time using hazard ratio (HR) and 95% condence interval (CI). Results: The Gene Expression Omnibus dataset showed that high Stabilin-2STAB2 expression implies longer overall survival (HR after correction = 0.541; 95% CI, 0.339–0.865; p = 0.0182, after correction p = 0.010) and longer recurrence-free survival time (adjusted HR = 0.554; 95% CI, 0.376-0.816; p = 0.0085, adjusted p = 0.003). Conclusions: STAB2 is a potential biomarker for the diagnosis and prognosis of HCC. Background Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor worldwide, and the third leading cause of cancer-related deaths accounting for 8.2% of all cancer deaths. China contributes to about half of the new liver cancer cases and deaths recorded worldwide every year[1, 2]. Hepatocellular carcinoma accounts for about 90% of liver tumors and causes more than 700,000 deaths worldwide each year due to poor prognosis [3, 4]. Cirrhosis is a main hepatocellular carcinoma risk factor and about 70- 90% of hepatocellular carcinoma patients have a cirrhosis history[5]. Chronic hepatitis B virus (HBV) infection is one of the high risk factors for human HCC, accounting for 50% to 80% of the HCC cases worldwide[6]. In addition, alcoholism, aatoxin B1 intake, non-alcoholic fatty liver and hepatitis C virus are also risk factors for hepatocellular carcinoma[7-9] . Although surgical resection and liver transplantation can effectively treat HCC, the 5-year overall survival rate remains at 7% [10]. Early screening for liver cancer relies on liver ultrasound and alpha-fetoprotein (AFP) [11]. However, ultrasound monitoring is limited by low detection sensitivity, which often leads to misdiagnosis of malignant nodules[12]. AFP is also reported to have low sensitivity and specicity [13]. Recent studies have reported potential HCC diagnostic markers such as protein induced by vitamin K absence or antagonist-II (PIVKA-II), Lens culinaris-agglutinin-reactive fraction of AFP (AFP-L3), MicroRNA-4651 (miR-4651) and MicroRNA-125b (miR-125b) [14-17]. HCC diagnosis using these markers requires invasive procedures, therefore, there is need to identify non-invasive biomarkers. Stabilin-1(STAB1) and Stabilin-2(STAB2) also known as FEEL-1and FEEL-2, are structurally highly conserved type I transmembrane proteins and members of the scavenger receptor family [18]. Previous Page 2/20 studies report that STAB is implicated in the proliferation and distant metastasis of melanoma cells, lymph node metastasis of prostate cancer and tongue cancer[19-21]. However, few studies have explored STAB expression in HCC. Therefore, our study utilized multiple datasets to explore the relationship between STAB expression levels and HCC. Materials And Methods Patient information We retrieved STAB1 and STAB2 mRNA expression levels data for HCC patients from The Cancer Genome Atlas (TCGA) database. We normalized and transformed the raw data using R software (RStudio 1.2.5001 Inc., Boston, MA, USA). The expression levels were classied into high and low groups using a 50% cutoff value. Processed data for 370 patients including race, gender, age, TNM stage, body mass index (BMI), family history, survival status and time were also retrieved. Further, the GSE14520 dataset consisting of [HT_HG-U133A] Affymetrix HT human genome U133A array (445 samples) and [HT_HG-U133A_2] Affymetrix HT human genome U133A genes was downloaded from the Gene Expression Synthesis (GEO) database. The expression data consisted of a 2.0 array (57 samples) [22, 23]. To avoid batch effects, we obtained mRNA expression data from 221 HCC patients selected from the TCGA dataset . The mRNA expression levels in 221 HCC patients were also divided into two groups using a 50% cutoff value . GraphPad Prism version 7.0 (GraphPad Software, La Jolla, CA, USA) for Windows was used to assess differential gene expression between primary liver tumors and normal liver tissues. Mutations in the STAB gene family were veried using cBioPortal webserver for Cancer Genomics. Survival analysis We evaluated the prognosis of HCC patients from the TCGA database using median survival time (MST) and we adjusted for race, gender, age, BMI, TNM staging, and family history using the Cox regression model. We assessed the prognosis of HCC patients in the GEO database using the overall survival (OS) and recurrence-free survival (RFS). Further, we adjusted for gender, age, hepatitis B virus (HBV) infection status, alanine aminotransferase (ALT) status, main tumor size, multinodule status, cirrhosis, alphafetoprotein (AFP) level, and Barcelona Clinic Liver Cancer (BCLC) stage using the Cox proportional hazards regression model in the GEO database. Stratied chi-square test We stratied the data and calculated the MST, hazard ratio (HR) at 95% condence interval (CI). These data revealed differences in the different layers. Functional enrichment analysis Page 3/20 We performed a gene ontology (GO) functional analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis using Metascape (a gene annotation and analysis tool) and the Database for Annotation, Visualization, and Integrated Discovery (DAVID) version 6.8[24-26]. In GO analysis, we assessed biological processes, cellular components, and molecular functions. Further, we used the STRING (Search Interaction Gene / Protein Search Tool) database to predict protein-protein interactions between STAB gene family members and other proteins [27]. Statistical Analysis We used GraphPad Prism version 7.0 for Windows to generate survival curves and forest plots. All other statistical analyses were performed using SPSS version 22 (SPSS Inc., Chicago, IL, USA). P<0.05 was considered statistically signicant. Result Gene expression in tumors and normal tissues Presentation of STAB1 and STAB2 expression data from the TCGA dataset on a scatter plot showed that these two factors have different expressions levels (Fig. 1a, b). However, STAB1 and STAB2 were not differentially expressed (Fig. 1c, d) in tumor tissues and normal tissues of the GEO dataset. In addition, 7% of cancer samples showed STAB1 mutations, including missense mutation, truncating mutation, amplication, and deep deletion. Further, 5% of cancer samples showed mutations in the STAB2 gene including missense mutation, truncating mutation, amplication (Fig. 1e). Basic patient information Detailed information on the 370 HCC patients in TCGA database is shown in Table 1. BMI and TNM staging showed a signicant correlation with MST (p = 0.021 and <0.001, respectively). Information on patients evaluated in the GEO database is shown in Table 2. Major tumor size, TNM stage, cirrhosis, BCLC stage, and alpha-fetoprotein levels were signicantly correlated with OS (p = 0.003, 0.019, <0.001, <0.001, <0.001, 0.032, 0.019, and 0.026, respectively). Further, Gender, TNM stage, and BCLC stage were signicantly correlated with RFS (p = 0.016, <0.001, and <0.001, respectively). Table 1 Basic characteristics of HCC patients in the TCGA database Page 4/20 Variables Patients No. of events MST HR Log-rank P (n=370) (%) months (95%CI) Race 0.127 Asian 157 44(28.0%) 82 Ref White+others 203 81(40.1%) 68 1.42(0.98-2.05) Missing 10 Gender 0.488 Male 249 79(31.7%) 57 Ref Female 121 51(42.1%) 59 1.07(0.89-1.28) Age 0.248 ≤60 177 55(31.1%) 71 Ref >60 193 75(38.9%) 52 1.23(0.87-1.75) BMI 0.021 ≤25 177 61(34.5%) 68 Ref >25 157 51(32.5%) 66 0.82(0.64-1.04) Missing 36 TNM staging <0.001 + 274 76(27.7%) 84 Ref + 94 54(57.4%) 26 2.40(1.69-3.41) Missing 2 Family history 0.192 Yes 112 49(44.1%) 40 Ref No 207 69(33.3%) 62 0.78(0.54-1.13) Missing 51 MST, median survival time; HR, hazard ratio; 95%CI, 95% confidence interval; Ref, reference; BMI, body mass index; TNM stage, tumor, node and metastasis stage. Survival analysis The TCGA data were analyzed using a multivariate Cox regression model with adjustment for race, gender, age, BMI, TNM stage, and family history, which showed no signicant correlation between STAB1 and STAB2 with prognosis (adjusted p=0.300 and 0.865 respectively) (Fig. 2a, b, g).GEO data were evaluated by a multiple Cox regression model, with adjustment for race, age, HBV, ALT, major tumor size, multiple nodule status, liver cirrhosis, TNM staging, BCLC staging, and AFP, showing that STAB2 was signicantly correlated with OS (HR = 0.541; 95% CI, 0.339–0.865; adjusted p = 0.010) and RFS (HR = 0.554; 95% CI, 0.376-0.816; adjusted p = 0.003) after adjustment (Fig.
Load more

Recommended publications
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Epigenetic Regulation of Murine Stab2 Expression in Determining Atherosclerotic Susceptibility
    EPIGENETIC REGULATION OF MURINE STAB2 EXPRESSION IN DETERMINING ATHEROSCLEROTIC SUSCEPTIBILITY Sharlene Dong A thesis submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Master of Science in the Department of Nutrition (Nutritional Biochemistry) in the Gillings School of Global Public Health Chapel Hill 2017 Approved by: Nobuyo Maeda Rosalind Coleman Eric L. Klett i © 2017 Sharlene Dong ALL RIGHTS RESERVED ii ABSTRACT Sharlene Dong: Epigenetic regulation of murine Stab2 expression in determining atherosclerotic susceptibility (Under the direction of Nobuyo Maeda) Atherosclerosis is a progressive disease characterized by the accumulation of lipids and fibrous elements in the arteries. In mice, the aortic arch and root show distinct patterns of lesion development. A quantitative trait locus (QTL) analysis of an intercross between apoE-null mice on 129S6 and DBA/2J backgrounds has revealed a significant locus on chromosome 10, Aath5, that affects plaque size in the arch. One candidate gene in the Aath5 locus is the Stab2 gene, which encodes a receptor for hyaluronan. The DBA allele of the Stab2 gene includes a unique intracisternal A-particle (IAP) retrotransposon inserted in reverse in the promoter region, which drives Stab2 expression. Methylation status of this region was analyzed through allele-specific bisulfite sequencing and correlated with ectopic Stab2 expression in the heart and kidneys. Thus, epigenetic regulation of this IAP element may play a role in regulating Stab2 expression and affect atherosclerotic susceptibility in the aortic arch. iii To my mom and dad and all my friends Sincerely thank you for your unwavering support in me.
    [Show full text]
  • Transcriptional Landscape of Pulmonary Lymphatic Endothelial Cells During Fetal Gestation
    RESEARCH ARTICLE Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation 1,2 3 1 1,4 Timothy A. Norman, Jr.ID *, Adam C. Gower , Felicia Chen , Alan Fine 1 Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America, 2 Pathology & Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America, 3 Clinical and Translational Science Institute, Boston University School of Medicine, Boston, Massachusetts, United States of America, 4 Boston Veteran's Hospital, West Roxbury, a1111111111 Massachusetts, United States of America a1111111111 a1111111111 * [email protected] a1111111111 a1111111111 Abstract The genetic programs responsible for pulmonary lymphatic maturation prior to birth are not known. To address this gap in knowledge, we developed a novel cell sorting strategy to col- OPEN ACCESS lect fetal pulmonary lymphatic endothelial cells (PLECs) for global transcriptional profiling. Citation: Norman TA, Jr., Gower AC, Chen F, Fine A We identified PLECs based on their unique cell surface immunophenotype (CD31+/Vegfr3 (2019) Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation. +/Lyve1+/Pdpn+) and isolated them from murine lungs during late gestation (E16.5, E17.5, PLoS ONE 14(5): e0216795. https://doi.org/ E18.5). Gene expression profiling was performed using whole-genome microarrays, and 10.1371/journal.pone.0216795 1,281 genes were significantly differentially expressed with respect to time (FDR q < 0.05) Editor: Vladimir V. Kalinichenko, Cincinnati and grouped into six clusters. Two clusters containing a total of 493 genes strongly upregu- Children's Hospital Medical Center, UNITED lated at E18.5 were significantly enriched in genes with functional annotations correspond- STATES ing to innate immune response, positive regulation of angiogenesis, complement & Received: October 19, 2018 coagulation cascade, ECM/cell-adhesion, and lipid metabolism.
    [Show full text]
  • Comprehensive Analysis Reveals Novel Gene Signature in Head and Neck Squamous Cell Carcinoma: Predicting Is Associated with Poor Prognosis in Patients
    5892 Original Article Comprehensive analysis reveals novel gene signature in head and neck squamous cell carcinoma: predicting is associated with poor prognosis in patients Yixin Sun1,2#, Quan Zhang1,2#, Lanlin Yao2#, Shuai Wang3, Zhiming Zhang1,2 1Department of Breast Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; 2School of Medicine, Xiamen University, Xiamen, China; 3State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, China Contributions: (I) Conception and design: Y Sun, Q Zhang; (II) Administrative support: Z Zhang; (III) Provision of study materials or patients: Y Sun, Q Zhang; (IV) Collection and assembly of data: Y Sun, L Yao; (V) Data analysis and interpretation: Y Sun, S Wang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Zhiming Zhang. Department of Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China. Email: [email protected]. Background: Head and neck squamous cell carcinoma (HNSC) remains an important public health problem, with classic risk factors being smoking and excessive alcohol consumption and usually has a poor prognosis. Therefore, it is important to explore the underlying mechanisms of tumorigenesis and screen the genes and pathways identified from such studies and their role in pathogenesis. The purpose of this study was to identify genes or signal pathways associated with the development of HNSC. Methods: In this study, we downloaded gene expression profiles of GSE53819 from the Gene Expression Omnibus (GEO) database, including 18 HNSC tissues and 18 normal tissues.
    [Show full text]
  • Genes Associated with Anhedonia
    Ren et al. Translational Psychiatry (2018) 8:150 DOI 10.1038/s41398-018-0198-3 Translational Psychiatry ARTICLE Open Access Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP) Hongyan Ren1, Chiara Fabbri2, Rudolf Uher3, Marcella Rietschel 4,OleMors5, Neven Henigsberg 6,JoannaHauser7, Astrid Zobel8, Wolfgang Maier8, Mojca Z. Dernovsek9,DanielSouery10, Annamaria Cattaneo11, Gerome Breen2, Ian W. Craig2,AnneE.Farmer2,PeterMcGuffin2, Cathryn M. Lewis 2 and Katherine J. Aitchison 1,2 Abstract A key feature of major depressive disorder (MDD) is anhedonia, which is a predictor of response to antidepressant treatment. In order to shed light on its genetic underpinnings, we conducted a genome-wide association study (GWAS) followed by investigation of biological pathway enrichment using an anhedonia dimension for 759 patients with MDD in the GENDEP study. The GWAS identified 18 SNPs associated at genome-wide significance with the top one being an intronic SNP (rs9392549) in PRPF4B (pre-mRNA processing factor 4B) located on chromosome 6 (P = 2.07 × 10−9) while gene-set enrichment analysis returned one gene ontology term, axon cargo transport (GO: 0008088) with a nominally significant P value (1.15 × 10−5). Furthermore, our exploratory analysis yielded some interesting, albeit not statistically significant genetic correlation with Parkinson’s Disease and nucleus accumbens gray matter. In addition, polygenic risk scores (PRSs) generated from our association analysis were found to be able to predict treatment efficacy of the antidepressants in this study. In conclusion, we found some markers significantly associated with anhedonia, and some suggestive findings of related pathways and biological functions, which could be further investigated in other studies.
    [Show full text]
  • Quantitative Trait Loci Mapping of Macrophage Atherogenic Phenotypes
    QUANTITATIVE TRAIT LOCI MAPPING OF MACROPHAGE ATHEROGENIC PHENOTYPES BRIAN RITCHEY Bachelor of Science Biochemistry John Carroll University May 2009 submitted in partial fulfillment of requirements for the degree DOCTOR OF PHILOSOPHY IN CLINICAL AND BIOANALYTICAL CHEMISTRY at the CLEVELAND STATE UNIVERSITY December 2017 We hereby approve this thesis/dissertation for Brian Ritchey Candidate for the Doctor of Philosophy in Clinical-Bioanalytical Chemistry degree for the Department of Chemistry and the CLEVELAND STATE UNIVERSITY College of Graduate Studies by ______________________________ Date: _________ Dissertation Chairperson, Johnathan D. Smith, PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, David J. Anderson, PhD Department of Chemistry, Cleveland State University ______________________________ Date: _________ Dissertation Committee member, Baochuan Guo, PhD Department of Chemistry, Cleveland State University ______________________________ Date: _________ Dissertation Committee member, Stanley L. Hazen, MD PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, Renliang Zhang, MD PhD Department of Cellular and Molecular Medicine, Cleveland Clinic ______________________________ Date: _________ Dissertation Committee member, Aimin Zhou, PhD Department of Chemistry, Cleveland State University Date of Defense: October 23, 2017 DEDICATION I dedicate this work to my entire family. In particular, my brother Greg Ritchey, and most especially my father Dr. Michael Ritchey, without whose support none of this work would be possible. I am forever grateful to you for your devotion to me and our family. You are an eternal inspiration that will fuel me for the remainder of my life. I am extraordinarily lucky to have grown up in the family I did, which I will never forget.
    [Show full text]
  • Ectopic Expression of the Stabilin2 Gene Triggered by an Intracisternal a Particle (IAP) Element in DBA/2J Strain of Mice
    Mammalian Genome (2020) 31:2–16 https://doi.org/10.1007/s00335-019-09824-1 Ectopic expression of the Stabilin2 gene triggered by an intracisternal A particle (IAP) element in DBA/2J strain of mice Nobuyo Maeda‑Smithies1 · Sylvia Hiller1 · Sharlene Dong1,3 · Hyung‑Suk Kim1 · Brian J. Bennett2,4 · Yukako Kayashima1 Received: 1 November 2019 / Accepted: 29 December 2019 / Published online: 7 January 2020 © The Author(s) 2020 Abstract Stabilin2 (Stab2) encodes a large transmembrane protein which is predominantly expressed in the liver sinusoidal endothelial cells (LSECs) and functions as a scavenger receptor for various macromolecules including hyaluronans (HA). In DBA/2J mice, plasma HA concentration is ten times higher than in 129S6 or C57BL/6J mice, and this phenotype is genetically linked to the Stab2 locus. Stab2 mRNA in the LSECs was signifcantly lower in DBA/2J than in 129S6, leading to reduced STAB2 proteins in the DBA/2J LSECs. We found a retrovirus-derived transposable element, intracisternal A particle (IAP), DBA in the promoter region of Stab2 which likely interferes with normal expression in the LSECs. In contrast, in other tissues DBA of DBA/2J mice, the IAP drives high ectopic Stab2 transcription starting within the 5′ long terminal repeat of IAP in a DBA reverse orientation and continuing through the downstream Stab2 . Ectopic transcription requires the Stab2-IAP element but is dominantly suppressed by the presence of loci on 59.7–73.0 Mb of chromosome (Chr) 13 from C57BL/6J, while the same region in 129S6 requires additional loci for complete suppression. Chr13:59.9–73 Mb contains a large number of genes encoding Krüppel-associated box-domain zinc-fnger proteins that target transposable elements-derived sequences and DBA repress their expression.
    [Show full text]
  • Differential Gene Expression by RNA-Seq Analysis of the Primo Vessel in the Rabbit Lymph
    J Acupunct Meridian Stud 2019;12(1):11e19 Available online at www.sciencedirect.com Journal of Acupuncture and Meridian Studies journal homepage: www.jams-kpi.com Research Article Differential Gene Expression by RNA-Seq Analysis of the Primo Vessel in the Rabbit Lymph Jun-Young Shin, Sang-Heon Choi, Da-Woon Choi, Ye-Jin An, Jae-Hyuk Seo, Jong-Gu Choi, Min-Suk Rho, Sang-Suk Lee* Department of Oriental Biomedical Engineering, Sangji University, Wonju, Republic of Korea Available online 28 October 2018 Received: May 31, 2018 Abstract Revised: Jul 26, 2018 For the connectome of primo vascular system, some long-type primo vessels dyed with Accepted: Oct 23, 2018 Alcian blue injected into inguinal nodes, abdominal node, and axially nodes were visual- ized, which passed over around the vena cava of the rabbit. The Alcian blue dye revealed KEYWORDS primo vessels and colored blue in the rabbit lymph vessels. The length of long-type primo e m gene expression level; vessels was 18 cm on average, of which diameters were about 20 30 m, and the lymph e m lymph node; vessels had diameters of 100 150 m. Three different tissues of pure primo vessel, mixed primo connectome; primo þ lymph vessel, and only lymph vessel were made to undergo RNA-Seq analysis by RNA-Seq analysis next-generation sequencing. We also analyzed differentially expressed genes (DEGs) from the RNA-Seq data, in which 30 genes of the primo vessels, primo þ lymph vessels, and lymph vessels were selected for primo marker candidates. From the plot of DEG analysis, 10 genes had remarkably different expression pattern on the Group 1 (primo vessel) vs Group 3 (lymph vessel).
    [Show full text]
  • Mouse Stab2 Conditional Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Stab2 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Stab2 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Stab2 gene (NCBI Reference Sequence: NM_138673 ; Ensembl: ENSMUSG00000035459 ) is located on Mouse chromosome 10. 69 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 69 (Transcript: ENSMUST00000035288). Exon 4 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Stab2 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-233D10 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for knock-out alleles exhibit no gross abnormaities. Mice homozygous for one null allele display elevated serum hyaluronic acid levels and decreased metastasis. Exon 4 starts from about 4.64% of the coding region. The knockout of Exon 4 will result in frameshift of the gene. The size of intron 3 for 5'-loxP site insertion: 15628 bp, and the size of intron 4 for 3'-loxP site insertion: 1090 bp. The size of effective cKO region: ~586 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 4 5 69 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Stab2 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Mouse Stab2 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Stab2 Knockout Project (CRISPR/Cas9) Objective: To create a Stab2 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Stab2 gene (NCBI Reference Sequence: NM_138673 ; Ensembl: ENSMUSG00000035459 ) is located on Mouse chromosome 10. 69 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 69 (Transcript: ENSMUST00000035288). Exon 2~3 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for knock-out alleles exhibit no gross abnormaities. Mice homozygous for one null allele display elevated serum hyaluronic acid levels and decreased metastasis. Exon 2 starts from about 1.38% of the coding region. Exon 2~3 covers 3.26% of the coding region. The size of effective KO region: ~6291 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 69 Legends Exon of mouse Stab2 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of Exon 3 is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • An Integrative Genomic Analysis of the Longshanks Selection Experiment for Longer Limbs in Mice
    bioRxiv preprint doi: https://doi.org/10.1101/378711; this version posted August 19, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Title: 2 An integrative genomic analysis of the Longshanks selection experiment for longer limbs in mice 3 Short Title: 4 Genomic response to selection for longer limbs 5 One-sentence summary: 6 Genome sequencing of mice selected for longer limbs reveals that rapid selection response is 7 due to both discrete loci and polygenic adaptation 8 Authors: 9 João P. L. Castro 1,*, Michelle N. Yancoskie 1,*, Marta Marchini 2, Stefanie Belohlavy 3, Marek 10 Kučka 1, William H. Beluch 1, Ronald Naumann 4, Isabella Skuplik 2, John Cobb 2, Nick H. 11 Barton 3, Campbell Rolian2,†, Yingguang Frank Chan 1,† 12 Affiliations: 13 1. Friedrich Miescher Laboratory of the Max Planck Society, Tübingen, Germany 14 2. University of Calgary, Calgary AB, Canada 15 3. IST Austria, Klosterneuburg, Austria 16 4. Max Planck Institute for Cell Biology and Genetics, Dresden, Germany 17 Corresponding author: 18 Campbell Rolian 19 Yingguang Frank Chan 20 * indicates equal contribution 21 † indicates equal contribution 22 Abstract: 23 Evolutionary studies are often limited by missing data that are critical to understanding the 24 history of selection. Selection experiments, which reproduce rapid evolution under controlled 25 conditions, are excellent tools to study how genomes evolve under strong selection. Here we 1 bioRxiv preprint doi: https://doi.org/10.1101/378711; this version posted August 19, 2018.
    [Show full text]
  • INTRODUCING a NOVEL METHOD for GENETIC ANALYSIS of AUTISM SPECTRUM DISORDER Sepideh Nouri
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2013 INTRODUCING A NOVEL METHOD FOR GENETIC ANALYSIS OF AUTISM SPECTRUM DISORDER sepideh nouri Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Bioinformatics Commons, Computational Biology Commons, and the Genomics Commons Recommended Citation nouri, sepideh, "INTRODUCING A NOVEL METHOD FOR GENETIC ANALYSIS OF AUTISM SPECTRUM DISORDER" (2013). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 417. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/417 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. INTRODUCING A NOVEL METHOD FOR GENETIC ANALYSIS OF AUTISM SPECTRUM DISORDER by Sepideh Nouri, M.S. APPROVED: Eric Boerwinkle, Ph.D., Supervisor Kim-Anh Do, Ph.D. Alanna Morrison, Ph.D. James Hixson, Ph.D. Paul Scheet, Ph.D. APPROVED: Dean, The University of Texas Graduate School of Biomedical Sciences at Houston INTRODUCING A NOVEL METHOD FOR GENETIC ANALYSIS OF AUTISM SPECTRUM DISORDER A THESIS Presented to the Faculty of The University of Texas Health Science Center at Houston and The University of Texas M.
    [Show full text]